https://scholars.lib.ntu.edu.tw/handle/123456789/568459
標題: | Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence [2] | 作者: | Yeh Y.-C. PEI-JER CHEN Lai M.-S. |
公開日期: | 2013 | 出版社: | American Medical Association | 卷: | 309 | 期: | 8 | 起(迄)頁: | 765-766 | 來源出版物: | JAMA - Journal of the American Medical Association | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874389116&doi=10.1001%2fjama.2013.571&partnerID=40&md5=89a6d6f6f6947d3b0e885e68990fcc64 https://scholars.lib.ntu.edu.tw/handle/123456789/568459 |
ISSN: | 0098-7484 | DOI: | 10.1001/jama.2013.571 | SDG/關鍵字: | antivirus agent; nucleoside analog; advanced cancer; antiviral therapy; cancer staging; disease association; drug effect; drug efficacy; drug exposure; drug response; hepatitis B; human; letter; liver cell carcinoma; liver resection; observational study; priority journal; recurrent cancer; risk assessment; risk reduction; survival rate; survival time; treatment duration; tumor volume; female; liver cell carcinoma; liver tumor; male; note; pathology; virology; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B; Humans; Liver Neoplasms; Male |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。